Repaglinide 2mg tablets
BNF presentation 0601023R0AAACAC within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0601023R0AAACAC
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
3,832
NHS spend (£)
£30,194.90
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 436 |
| February 2025 | 12 |
| December 2024 | 134 |
| November 2024 | 527 |
| October 2024 | 454 |
| September 2024 | 1 |
| August 2024 | 52 |
| July 2024 | 496 |
| May 2024 | 145 |
| July 2021 | 154 |
| June 2021 | 126 |
| December 2020 | 580 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 85 | No data available |
| Unknown pharmacy | 39 | No data available |
| Unknown pharmacy | 36 | No data available |
| Unknown pharmacy | 34 | No data available |
| Unknown pharmacy | 32 | No data available |
| Unknown pharmacy | 31 | No data available |
| Unknown pharmacy | 30 | No data available |
| Unknown pharmacy | 28 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 26 | No data available |